1340. Population Pharmacokinetic (PK) Analysis of APX001 Using Phase 1 Data

por Trang, Michael, Bader, Justin C, Ople, Eric A, Kramer, William G, Hodges, Michael R, Bhavnani, Sujata M, Rubino, Christopher M
Publicado 2018

Population Pharmacokinetic Analyses for Plazomicin Using Pooled Data from Phase 1, 2, and 3 Clinical Studies

por Trang, Michael, Seroogy, Julie D., Van Wart, Scott A., Bhavnani, Sujata M., Kim, Aryun, Gibbons, Jacqueline A., Ambrose, Paul G., Rubino, Christopher M.
Publicado 2019

Population Pharmacokinetic Analyses for Omadacycline Using Phase 1 and 3 Data

por Lakota, Elizabeth A., Van Wart, Scott A., Trang, Michael, Tzanis, Evan, Bhavnani, Sujata M., Safir, M. Courtney, Friedrich, Lawrence, Steenbergen, Judith N., Ambrose, Paul G., Rubino, Christopher M.
Publicado 2020

733. Pharmacokinetic–Pharmacodynamic (PK–PD) Analyses for Alanine Aminotransferase (ALT) Using Phase 3 Data From Omadacycline (OMC)-Treated Patients

por Bhavnani, Sujata M, Trang, Michael, George, Darryl R, Liolios, Kathryn, McGovern, Paul C, Friedrich, Lawrence, Steenbergen, Judith N, Rubino, Christopher M, Tzanis, Evan, Ambrose, Paul G, Hammel, Jeffrey P
Publicado 2019

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising...

por Bhavnani, Sujata M., Hammel, Jeffrey P., Lakota, Elizabeth A., Trang, Michael, Bader, Justin C., Bulik, Catharine C., VanScoy, Brian D., Rubino, Christopher M., Huband, Michael D., Friedrich, Lawrence, Steenbergen, Judith N., Ambrose, Paul G.
Publicado 2023